Carbonic anhydrase inhibitors: Topical sulfonamide antiglaucoma agents incorporating secondary amine moieties

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 7, 2000, Pages 673-676

  Renzi, Giovanni ^a   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; ANTIGLAUCOMA AGENT; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; CHEMICAL REACTION; CONTROLLED STUDY; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; GLAUCOMA; INTRAOCULAR PRESSURE; NONHUMAN; RABBIT; SOLUBILITY;

AMINES; ANIMALS; AQUEOUS HUMOR; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CATTLE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034599954     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00075-5     Document Type: Article

References (20)

1. Maren, T. H. Physiol. Rev. 1967, 47, 595.
2. Hewett-Emmett, D.; Tashian, R. E. Mol. Phylogenet. Evol. 1996, 5, 50-77.
3. Briganti, F.; Mangani, S.; Orioli, P.; Scozzafava, A.; Vernaglione, G.; Supuran, C. T. Biochemistry 1997, 36, 10384.
4. Supuran, C. T. In Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism; Puscas I., Ed.; Helicon: Timisoara, 1994, pp 29-112.
5. Supuran, C. T.; Conroy, C. W.; Maren, T. H. Eur. J. Med. Chem. 1996, 31, 843.
6. Roblin, R. O.; Clapp, J. W. J. Am. Chem. Soc. 1950, 72, 4890.
7. Maren, T. H. J. Glaucoma 1995, 4, 49.
8. Reiss, W. G.; Oles, K. S. Ann. Pharmacother. 1996, 30, 514.
9. Becker, B. Am. J. Ophthalmol. 1955, 39, 177.
10. Maren, T. H.; Jankowska, L.; Edelhauser, G. F.; Sanyal, G. Exp. Eye Res. 1983, 36, 457.
11. Ponticello, G. S.; Freedman, M. B.; Habecker, C. N.; Lyle, P. A.; Schwam, H.; Varga, S. L.; Christy, M. E.; Randall, W. C.; Baldwin, J. J. J. Med. Chem. 1987, 30, 591.
12. (a) Scozzafava, A.; Briganti, F.; Mincione, G.; Menabuoni, L.; Mincione, F.; Supuran, C. T. J. Med. Chem. 1999, 42, 3690;
13. (b) Borras, J.; Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397.
14. Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. J. Med. Chem. 1999, 42, 2641.
15. Supuran, C. T.; Scozzafava, A.; Popescu, A.; Bobes-Tureac, R.; Banciu, A.; Creanga, A.; Bobes-Tureac, G.; Banciu, M. D. Eur. J. Med. Chem. 1997, 32, 445.
16. Mincione, F.; Menabuoni, L.; Briganti, F.; Mincione, G.; Scozzafava, A.; Supuran, C. T. J. Enz. Inhib. 1998, 13, 267.
17. Scozzafava, A.; Supuran, C. T. J. Enz. Inhib. 1998, 13, 419.
18. Pocker, Y.; Stone, J. T. Biochemistry 1967, 6, 668.
19. Maren, T. H.; Wynns, G. C.; Wistrand, P. J. Mol. Pharmacol. 1993, 44, 901.
20. Maren, T. H.; Brechue, W. F.; Bar-Ilan, A. Exp. Eye Res. 1992, 55, 73.